Literature DB >> 15096292

[Tuberculosis among city jail inmates in Campinas, São Paulo, Brazil].

Helenice Bosco de Oliveira1, Janaina Corrêa Cardoso.   

Abstract

OBJECTIVE: To describe the incidence of tuberculosis among inmates of the municipal prison system in the city of Campinas, State of São Paulo, Brazil, from 1993 through 2000.
METHODS: A retrospective study was carried out of the number of cases of tuberculosis that were notified among inmates over the study period. This involved reviewing data from a total of 4,293 inmates who were held in the four prisons that comprise Campinas' municipal prison system. Data were obtained from the tuberculosis database belonging to the Department of Social and Preventive Medicine of the School of Medical Sciences at the State University of Campinas.
RESULTS: The incidence of tuberculosis peaked in 1994 (1,397.62 cases per 100,000) and was lowest in 1999 (559.04 cases per 100,000). Most cases of tuberculosis occurred in inmates in the 25 to 34 year age group (62.6%). Acquired immunodeficiency syndrome (AIDS) was the disease most commonly associated with tuberculosis (49.9%), which was most often pulmonary in type (91.9%), with positive sputum smears in 70.3% of the inmates tested. Most inmates had not received treatment before (75.4%). The treatment dropout rate reached 49%, and a cure was achieved in only 20.8% of the cases notified over the study period.
CONCLUSIONS: The incidence of tuberculosis observed in this study was moderate when compared to incidence rates found in other studies of prison inmates, but this could be due to underreporting. The frequency of treatment failure noted was low, since patients who were treated under supervision showed good adherence and were cured in the majority of cases. However, the high treatment dropout rate seen in the study is alarming because it could facilitate the spread of drug resistant strains of Mycobacterium tuberculosis to the community at large. Controlling tuberculosis among prison inmates should be part of routine interventions aimed at eliminating this disease from the community and at preventing resistance to antituberculosis therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15096292     DOI: 10.1590/s1020-49892004000300008

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  6 in total

1.  Prevalence of patients with respiratory symptoms through active case finding and diagnosis of pulmonary tuberculosis among prisoners and related predictors in a jail in the city of Carapicuíba, Brazil.

Authors:  Amadeu A Vieira; Sandra A Ribeiro; Ana M de Siqueira; Vera M N Galesi; Laedi A R dos Santos; Jonathan E Golub
Journal:  Rev Bras Epidemiol       Date:  2010-12

Review 2.  Recent tuberculosis advances in Latin America.

Authors:  Tom Pelly; David A J Moore; Robert Gilman; Carlton Evans
Journal:  Curr Opin Infect Dis       Date:  2004-10       Impact factor: 4.915

Review 3.  Tuberculosis incidence in prisons: a systematic review.

Authors:  Iacopo Baussano; Brian G Williams; Paul Nunn; Marta Beggiato; Ugo Fedeli; Fabio Scano
Journal:  PLoS Med       Date:  2010-12-21       Impact factor: 11.069

4.  Dental caries experience and use of dental services among Brazilian prisoners.

Authors:  Alessandro Leite Cavalcanti; Iris Sant Anna Araujo Rodrigues; Ingrid Thays de Melo Silveira; Thaliny Batista Sarmento de Oliveira; Magaly Suenya de Almeida Pinto; Alidianne Fabia Cabral Xavier; Ricardo Dias de Castro; Wilton Wilney Nascimento Padilha
Journal:  Int J Environ Res Public Health       Date:  2014-11-25       Impact factor: 3.390

5.  A comparative study on the prevalence and risk factors of tuberculosis among the prisoners in khuzestan, South-west iran.

Authors:  Seyed Mohammad Alavi; Pejman Bakhtiarinia; Mehdi Eghtesad; Ali Albaji; Shokrolah Salmanzadeh
Journal:  Jundishapur J Microbiol       Date:  2014-12-01       Impact factor: 0.747

Review 6.  Prisoners co-infected with tuberculosis and HIV: a systematic review.

Authors:  Chantal L Edge; Emma J King; Kate Dolan; Martin McKee
Journal:  J Int AIDS Soc       Date:  2016-11-15       Impact factor: 5.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.